Lauren Silvernail, CFO & CBO at Revance Therapeutics, holds 1.00K shares in Harrow Health (Ticker: HROW), holds 0.00 shares in Dynavax (Ticker: DVAX), holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP). Most recently, Lauren Silvernail Bought ― shares of Harrow Health on May 19, 2026 for an estimated value of $31.00K.
Lauren Silvernail latest transaction was an Informative Buy of $31.00K.
What was Lauren Silvernail's most profitable transaction?
Lauren Silvernail’s most profitable transaction was an Informative Buy of RVNC stock on December 12, 2014. The return on the trade was 101.20%.
What is Lauren Silvernail's role in Revance Therapeutics?
Lauren Silvernail's role in Revance Therapeutics is CFO & CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.